News Snapshot:
Chinese vaccine Sinopharm has already succeeded in proving its efficacy is solid and far-better than AstraZeneca, Pfizer BioNTech, Johnson & Johnson and Moderna. By vaccinating only, a portion of the population, Bangladesh and Pakistan are already witnessing fast decline in the number of COVID cases, while India, even after vaccinating over 50 percent of its population mostly with AstraZeneca is struggling in containing the huge numbers of new cases every day. Similarly, the United States, Britain and the EU countries currently are witnessing massive rise in the number of new cases, while Russia’s Sputnik V vaccine is almost proved to...
